In support of this, our data in vitro and in vivo data demonstrated that KIF4A promotes phenotypes associated with poor prognosis in mCRPC, irrespective of AR status, suggesting KIF4A is a driver gene that promotes disease progression in human prostate cancers. The gene discussed is AR; the disease is Familial prostate cancer.